Covidien (COV) announced it will sell its Confluent Surgical line to Integra LifeSciences (IART) probably effective by March 31, 2014, pending regulatory approval. The product line brought in $65 million for the medical devices company in 2012. Integra will pay $235 million for the line, which includes DuraSeal, the first FDA-approved product that provides watertight […]
Ben Shappley, president and chief executive since 2006 of SpineMatrix Inc., developer of a device that diagnoses the source of lower back pain in a unique way, has gone to work for Amedica Corp. in Salt Lake City, Utah. Shappley led the company through the completion of its clinical trial and regulatory clearance processes. Shappley helped SpineMatrix through its clinical trials and regulatory clearance, and to land $8 million in its second round of financing.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.